September 29, 2021 Uncategorized BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies Read More
September 27, 2021 Company BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders Read More
September 22, 2021 GlobeNewswire BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile Read More
September 13, 2021 GlobeNewswire BetterLife to Present at the Emerging Growth Conference on September 15, 2021 Read More
September 9, 2021 GlobeNewswire BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A Neurological Receptor Studies Read More
August 25, 2021 GlobeNewswire BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2 Read More
July 27, 2021 GlobeNewswire BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile Read More
July 22, 2021 GlobeNewswire BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety Read More
July 15, 2021 GlobeNewswire Early Results of BetterLife Preclinical Study Showing AP-003 (rhIFNa2b) has Similar Potent Efficacy Against Different Variants of COVID-19 Read More